Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor L Schell

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Gastroenterology & Hepatology|February 28, 2024
A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and EfficacyTrevor L Schell, Freddy Caldera
Organic & Biomolecular Chemistry|December 5, 2014
Unraveling the contributions of hydrogen-bonding interactions to the activity of native and non-native ligands in the quorum-sensing receptor LasRJoseph P Gerdt, Christine E McInnis, Trevor L Schell, et al.
Archives of Osteoporosis|February 24, 2021
Opportunistic use of dual-energy X-ray absorptiometry to evaluate lumbar scoliosisTrevor L Schell, Diane Krueger, Neil Binkley, et al.
Crohn'S & Colitis 360|April 24, 2026
Influenza vaccine uptake among patients with inflammatory bowel disease: comparable outcomes between telemedicine and in-person careMazen Almasry, Trevor L Schell, Luke Richard, et al.
Chemistry & Biology|September 23, 2014
Mutational analysis of the quorum-sensing receptor LasR reveals interactions that govern activation and inhibition by nonlactone ligandsJoseph P Gerdt, Christine E McInnis, Trevor L Schell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2021
High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel DiseaseTrevor L Schell, Luke J Richard, Katharine Tippins, et al.
Inflammatory Bowel Diseases|September 20, 2024
Safety of Rotavirus Vaccination in Infants That Were Exposed to Biologics In Utero: A Systematic ReviewTrevor L Schell, Lucas Fass, Mary E Hitchcock, et al.
WMJ : Official Publication of the State Medical Society of Wisconsin|January 5, 2024
Uptake Rates of Three COVID-19 Vaccine Doses and Risk Factors for Incomplete Vaccination Among Patients With Inflammatory Bowel Disease Residing in Wisconsin: A Single-Center CohortTrevor L Schell, Miguel A Mailig, Mazen Almasry, et al.
Clinical and Translational Gastroenterology|May 5, 2025
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
Clinical and Translational Gastroenterology|February 13, 2024
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Gastroenterology & Hepatology|February 28, 2024
A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and EfficacyTrevor L Schell, Freddy Caldera
Organic & Biomolecular Chemistry|December 5, 2014
Unraveling the contributions of hydrogen-bonding interactions to the activity of native and non-native ligands in the quorum-sensing receptor LasRJoseph P Gerdt, Christine E McInnis, Trevor L Schell, et al.
Archives of Osteoporosis|February 24, 2021
Opportunistic use of dual-energy X-ray absorptiometry to evaluate lumbar scoliosisTrevor L Schell, Diane Krueger, Neil Binkley, et al.
Crohn'S & Colitis 360|April 24, 2026
Influenza vaccine uptake among patients with inflammatory bowel disease: comparable outcomes between telemedicine and in-person careMazen Almasry, Trevor L Schell, Luke Richard, et al.
Chemistry & Biology|September 23, 2014
Mutational analysis of the quorum-sensing receptor LasR reveals interactions that govern activation and inhibition by nonlactone ligandsJoseph P Gerdt, Christine E McInnis, Trevor L Schell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2021
High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel DiseaseTrevor L Schell, Luke J Richard, Katharine Tippins, et al.
Inflammatory Bowel Diseases|September 20, 2024
Safety of Rotavirus Vaccination in Infants That Were Exposed to Biologics In Utero: A Systematic ReviewTrevor L Schell, Lucas Fass, Mary E Hitchcock, et al.
WMJ : Official Publication of the State Medical Society of Wisconsin|January 5, 2024
Uptake Rates of Three COVID-19 Vaccine Doses and Risk Factors for Incomplete Vaccination Among Patients With Inflammatory Bowel Disease Residing in Wisconsin: A Single-Center CohortTrevor L Schell, Miguel A Mailig, Mazen Almasry, et al.
Clinical and Translational Gastroenterology|May 5, 2025
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
Clinical and Translational Gastroenterology|February 13, 2024
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
Pageof 2